Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.8K
Coagulation01:06

Coagulation

1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation01:09

Coagulation

8.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Fibrinolysis in Peripartum and Non-Pregnant Mares Using Modified Thromboelastography.

Animals : an open access journal from MDPI·2025
Same author

Perioperative factors and outcomes associated with antimicrobial therapy duration in horses undergoing exploratory celiotomy.

The Canadian veterinary journal = La revue veterinaire canadienne·2025
Same author

Prospective randomised comparison of different antimicrobial protocols for the prevention of surgical site infections in horses undergoing emergency exploratory celiotomy.

Equine veterinary journal·2025
Same author

Effect of Hypotension and Dobutamine on Gastrointestinal Microcirculations of Healthy, Anesthetized Horses.

Veterinary sciences·2024
Same author

Longitudinal evaluation of fentanyl concentrations in equine plasma and synovial fluid following application of transdermal fentanyl patches over one carpal joint.

Veterinary surgery : VS·2023
Same author

Postoperative sinusitis and pneumonia following exploratory celiotomy for treatment of colic in horses.

The Canadian veterinary journal = La revue veterinaire canadienne·2023
Same journal

Pharmaceutical and Nutraceutical Therapies for Liver Disease.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Clinical Signs of Liver Disease in Horses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Syndrome of High Gamma-Glutamyl Transferase in Racehorses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Equine Hepatology in Practice: Insights, Challenges, and Progress.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Pathophysiology and Treatment of Hepatic Encephalopathy.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Viral Hepatitis.

The Veterinary clinics of North America. Equine practice·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

8.0K

Coagulopathies in horses.

Kira L Epstein1

  • 1Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, 501 DW Brooks Dr, Athens, GA 30602, USA.

The Veterinary Clinics of North America. Equine Practice
|July 14, 2014
PubMed
Summary
This summary is machine-generated.

Primary coagulopathies are rare in horses, but inflammatory diseases often alter coagulation and fibrinolysis. Understanding hemostasis is key for interpreting diagnostic tests and guiding treatment for bleeding or clotting disorders.

Keywords:
DICHypercoagulationHyperfibrinolysisHypocoagulationHypofibrinolysis

More Related Videos

A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood
06:10

A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood

Published on: August 15, 2025

1.7K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 27, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
06:23

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

8.0K
A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood
06:10

A Simple Double Centrifugation Tube Method to Obtain Platelet-rich Plasma from Equine Blood

Published on: August 15, 2025

1.7K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Area of Science:

  • Veterinary Medicine
  • Equine Physiology
  • Hemostasis Research

Background:

  • Primary coagulopathies are uncommon in horses.
  • Coagulation and fibrinolysis are frequently altered in horses with inflammatory diseases.

Purpose of the Study:

  • To emphasize the importance of understanding normal and abnormal hemostasis in horses.
  • To guide the selection and interpretation of diagnostic tests for coagulation and fibrinolysis.
  • To inform treatment strategies for equine coagulopathies.

Main Methods:

  • Review of current literature on equine hemostasis.
  • Analysis of the pathophysiology of coagulation and fibrinolysis in inflammatory conditions.
  • Discussion of diagnostic approaches and therapeutic considerations.

Main Results:

  • Inflammatory diseases commonly induce changes in coagulation and fibrinolysis in horses.
  • Accurate interpretation of diagnostic tests relies on a solid understanding of hemostasis.
  • Treatment focuses on the underlying disease, with specific interventions for clinical coagulopathy signs.

Conclusions:

  • A thorough grasp of hemostasis is essential for equine veterinary diagnostics and therapeutics.
  • Management of equine coagulopathies involves addressing the primary disease and potential clinical signs.
  • Further research into equine hemostasis can improve patient outcomes.